NLRP3 and rheumatoid arthritis: Finally, our work provides a novel insight of epigenetic acetyltransferase KAT2A into the regulation of NLRP3 activation and IL‐1β production, which exhibits potential therapeutic approach for RA and relevant inflammatory diseases.